• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-取代吲唑作为构象锁定的4EGI-1模拟物和eIF4E/eIF4G相互作用的抑制剂。

3-substituted indazoles as configurationally locked 4EGI-1 mimetics and inhibitors of the eIF4E/eIF4G interaction.

作者信息

Yefidoff-Freedman Revital, Chen Ting, Sahoo Rupam, Chen Limo, Wagner Gerhard, Halperin Jose A, Aktas Bertal H, Chorev Michael

机构信息

Laboratory for Translational Research, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115 (USA); Hematology Laboratory for Translational Research, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 7, Boston, MA 02115 (USA).

出版信息

Chembiochem. 2014 Mar 3;15(4):595-611. doi: 10.1002/cbic.201300723. Epub 2014 Jan 23.

DOI:10.1002/cbic.201300723
PMID:24458973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4259117/
Abstract

4EGI-1, the prototypic inhibitor of eIF4E/eIF4G interaction, was identified in a high-throughput screening of small-molecule libraries with the aid of a fluorescence polarization assay that measures inhibition of binding of an eIF4G-derived peptide to recombinant eIF4E. As such, the molecular probe 4EGI-1 has potential for the study of molecular mechanisms involved in human disorders characterized by loss of physiological restraints on translation initiation. A hit-to-lead optimization campaign was carried out to overcome the configurational instability in 4EGI-1, which stems from the E-to-Z isomerization of the hydrazone function. We identified compound 1 a, in which the labile hydrazone was incorporated into a rigid indazole scaffold, as a promising rigidified 4EGI-1 mimetic lead. In a structure-activity relationship study directed towards probing the structural latitude of this new chemotype as an inhibitor of eIF4E/eIF4G interaction and translation initiation we identified 1 d, an indazole-based 4EGI-1 mimetic, as a new and improved lead inhibitor of eIF4E/eIF4G interaction and a promising molecular probe candidate for elucidation of the role of cap-dependent translation initiation in a host of pathophysiological states.

摘要

4EGI-1是eIF4E/eIF4G相互作用的原型抑制剂,它是在小分子文库的高通量筛选中借助荧光偏振测定法鉴定出来的,该测定法用于测量eIF4G衍生肽与重组eIF4E结合的抑制情况。因此,分子探针4EGI-1有潜力用于研究以翻译起始的生理限制丧失为特征的人类疾病所涉及的分子机制。开展了一项从活性命中物到先导化合物的优化工作,以克服4EGI-1中由于腙官能团的E-Z异构化导致的构型不稳定性。我们鉴定出化合物1a,其中不稳定的腙被并入刚性吲唑支架中,作为一种有前景的刚性化4EGI-1模拟先导化合物。在一项旨在探究这种新化学类型作为eIF4E/eIF4G相互作用和翻译起始抑制剂的结构自由度的构效关系研究中,我们鉴定出1d,一种基于吲唑的4EGI-1模拟物,作为eIF4E/eIF4G相互作用的新型改良先导抑制剂,以及用于阐明帽依赖性翻译起始在一系列病理生理状态中的作用的有前景的分子探针候选物。

相似文献

1
3-substituted indazoles as configurationally locked 4EGI-1 mimetics and inhibitors of the eIF4E/eIF4G interaction.3-取代吲唑作为构象锁定的4EGI-1模拟物和eIF4E/eIF4G相互作用的抑制剂。
Chembiochem. 2014 Mar 3;15(4):595-611. doi: 10.1002/cbic.201300723. Epub 2014 Jan 23.
2
Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G.真核翻译起始因子 eIF4E 与 4EGI-1 复合物的结构揭示了一种别构机制,可使 eIF4G 解离。
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):E3187-95. doi: 10.1073/pnas.1410250111. Epub 2014 Jul 21.
3
Structure-activity relationship study of 4EGI-1, small molecule eIF4E/eIF4G protein-protein interaction inhibitors.小分子eIF4E/eIF4G蛋白-蛋白相互作用抑制剂4EGI-1的构效关系研究
Eur J Med Chem. 2014 Apr 22;77:361-77. doi: 10.1016/j.ejmech.2014.03.034. Epub 2014 Mar 13.
4
Synthesis of rigidified eIF4E/eIF4G inhibitor-1 (4EGI-1) mimetic and their in vitro characterization as inhibitors of protein-protein interaction.刚性化 eIF4E/eIF4G 抑制剂-1(4EGI-1)类似物的合成及其作为蛋白-蛋白相互作用抑制剂的体外特性研究。
J Med Chem. 2014 Jun 26;57(12):5094-111. doi: 10.1021/jm401733v. Epub 2014 Jun 4.
5
The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.eIF4E/eIF4G 相互作用抑制剂 4EGI-1 通过下调 c-FLIP 和诱导 DR5,独立于抑制帽依赖性蛋白翻译,增强 TRAIL 介导的细胞凋亡。
Neoplasia. 2010 Apr;12(4):346-56. doi: 10.1593/neo.10144.
6
Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.小分子对翻译起始因子eIF4E和eIF4G之间相互作用的抑制作用
Cell. 2007 Jan 26;128(2):257-67. doi: 10.1016/j.cell.2006.11.046.
7
Design, synthesis and biological evaluation of bromophenol-thiazolylhydrazone hybrids inhibiting the interaction of translation initiation factors eIF4E/eIF4G as multifunctional agents for cancer treatment.设计、合成及生物评价溴酚噻唑腙类化合物抑制翻译起始因子 eIF4E/eIF4G 相互作用的活性 作为多功能抗肿瘤药物
Eur J Med Chem. 2019 Sep 1;177:153-170. doi: 10.1016/j.ejmech.2019.05.044. Epub 2019 May 20.
8
4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.4EGI-1 抑制帽依赖性翻译并调节恶性胸膜间皮瘤中的全基因组翻译。
Invest New Drugs. 2018 Apr;36(2):217-229. doi: 10.1007/s10637-017-0535-z. Epub 2017 Nov 8.
9
SUMO-2 promotes mRNA translation by enhancing interaction between eIF4E and eIF4G.SUMO-2通过增强真核翻译起始因子4E(eIF4E)与真核翻译起始因子4G(eIF4G)之间的相互作用来促进mRNA翻译。
PLoS One. 2014 Jun 27;9(6):e100457. doi: 10.1371/journal.pone.0100457. eCollection 2014.
10
Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1.4EGI-1双重活性的分子机制:使真核细胞起始因子4G(eIF4G)与真核细胞起始因子4E(eIF4E)解离,但稳定未磷酸化的4E结合蛋白1(4E-BP1)的结合
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4036-45. doi: 10.1073/pnas.1512118112. Epub 2015 Jul 13.

引用本文的文献

1
Thiazole Derivatives as Promising Candidates for Cryptococcosis Therapy.噻唑衍生物有望成为治疗隐球菌病的候选药物。
ACS Infect Dis. 2025 Mar 14;11(3):639-652. doi: 10.1021/acsinfecdis.4c00732. Epub 2025 Feb 7.
2
Thiazolotriazoles As Anti-infectives: Design, Synthesis, Biological Evaluation and Studies.噻唑并三唑类化合物作为抗感染药物:设计、合成、生物学评价及研究
ACS Omega. 2024 Feb 19;9(8):8846-8861. doi: 10.1021/acsomega.3c06324. eCollection 2024 Feb 27.
3
Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Translation Initiation Factor 4G.

本文引用的文献

1
Dual activators of protein kinase R (PKR) and protein kinase R-like kinase PERK identify common and divergent catalytic targets.蛋白激酶 R(PKR)和蛋白激酶 R 样激酶 PERK 的双重激活剂鉴定出共同和不同的催化靶标。
Chembiochem. 2013 Jul 8;14(10):1255-62. doi: 10.1002/cbic.201300177. Epub 2013 Jun 19.
2
Inhibition of α-helix-mediated protein-protein interactions using designed molecules.利用设计分子抑制α-螺旋介导的蛋白质-蛋白质相互作用。
Nat Chem. 2013 Mar;5(3):161-73. doi: 10.1038/nchem.1568.
3
Using a fragment-based approach to target protein-protein interactions.
考虑结合动力学在设计无序蛋白真核翻译起始因子 4E 结合蛋白 1 和真核翻译起始因子 4G 的肽模拟物中的应用。
J Med Chem. 2019 May 23;62(10):4967-4978. doi: 10.1021/acs.jmedchem.9b00068. Epub 2019 May 9.
4
High-Throughput Chemical Probing of Full-Length Protein-Protein Interactions.全长蛋白质-蛋白质相互作用的高通量化学探测
ACS Comb Sci. 2017 Dec 11;19(12):763-769. doi: 10.1021/acscombsci.7b00128. Epub 2017 Nov 14.
5
Signalling to eIF4E in cancer.癌症中向真核起始因子4E的信号传导。
Biochem Soc Trans. 2015 Oct;43(5):763-72. doi: 10.1042/BST20150126.
基于片段的方法靶向蛋白质-蛋白质相互作用。
Chembiochem. 2013 Feb 11;14(3):332-42. doi: 10.1002/cbic.201200521. Epub 2013 Jan 23.
4
Autism-related deficits via dysregulated eIF4E-dependent translational control.通过失调的 eIF4E 依赖性翻译控制导致的自闭症相关缺陷。
Nature. 2013 Jan 17;493(7432):371-7. doi: 10.1038/nature11628. Epub 2012 Nov 21.
5
Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.多重靶向测序鉴定自闭症谱系障碍中反复突变的基因。
Science. 2012 Dec 21;338(6114):1619-22. doi: 10.1126/science.1227764. Epub 2012 Nov 15.
6
Tumor suppression by small molecule inhibitors of translation initiation.通过翻译起始小分子抑制剂实现肿瘤抑制
Oncotarget. 2012 Aug;3(8):869-81. doi: 10.18632/oncotarget.598.
7
Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors.设计、合成及药理学评价 N-酰腙类化合物和新型构象限制化合物作为选择性和强效的口服磷酸二酯酶-4 抑制剂。
J Med Chem. 2012 Sep 13;55(17):7525-45. doi: 10.1021/jm300514y. Epub 2012 Aug 30.
8
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice.Tsc1 突变型浦肯野细胞小鼠的自闭症样行为和小脑功能障碍。
Nature. 2012 Aug 30;488(7413):647-51. doi: 10.1038/nature11310.
9
Fine-tuning multiprotein complexes using small molecules.使用小分子精细调节多蛋白复合物。
ACS Chem Biol. 2012 Aug 17;7(8):1311-20. doi: 10.1021/cb300255p. Epub 2012 Jul 23.
10
PTEN signaling in autism spectrum disorders.PTEN 信号在自闭症谱系障碍中的作用。
Curr Opin Neurobiol. 2012 Oct;22(5):873-9. doi: 10.1016/j.conb.2012.05.004. Epub 2012 Jun 2.